HopeStage
Back to all studies
CompletedNCT05823753

Cannabidiol and body responses related to anxiety

About this titleRead the official source — NCT05823753
Medication studyAges 18–70United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
San DiegoSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: April 19, 2023
Recruitment status
Completed
Enrollment listed in the registry
63
Sponsor
University of California, San Diego
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT05823753
Official title
Show the full official title

Endocannabinoid System Engagement to Reduce Anxiety Reactivity with Cannabidiol in Social Anxiety Disorder (R61 Project)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

San Diego

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, San Diego, a university.

Did this study involve medication?

Yes. The study involved medication, including Cannabidiol and Placebo.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies